Corteva, Inc.
Business
Corteva, Inc. is a global provider of seed and crop protection solutions for agriculture operating in approximately 110 countries. The company develops and supplies commercial seed combining germplasm with advanced traits, and provides crop protection products including herbicides, insecticides, fungicides, and biologicals to protect crop yields. Corteva operates through two reportable segments—Seed and Crop Protection—and distributes products via its unique Pioneer agency model, regional seed brands, retail channels, and third-party licensing arrangements.
Summary from 10-K filed 2026-02-12
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net Sales | 17,401 | 16,908 | 17,226 | 17,455 | 15,655 | |
| Cost of Goods Sold | 9,172 | 9,529 | 9,920 | 10,436 | 9,220 | |
| Research and Development Expense | 1,474 | 1,402 | 1,337 | 1,216 | 1,187 | |
| Selling, General and Administrative Expense | 3,492 | 3,196 | 3,176 | 3,173 | 3,209 | |
| Amortization of Intangibles | 644 | 685 | 683 | 702 | 722 | |
| Restructuring and asset related charges - net | 146 | 288 | 336 | 363 | — | |
| Business Separation Costs | 35 | 0 | 0 | — | — | |
| Other income (expense) - net | −570 | −300 | −448 | −60 | 1,348 | |
| Interest Expense | 180 | 233 | 233 | 79 | 30 | |
| Income (loss) from continuing operations before income taxes | 1,688 | 1,275 | 1,093 | 1,426 | 2,346 | |
| Provision for (benefit from) income taxes on continuing operations | 484 | 412 | 152 | 210 | 524 | |
| Income (loss) from continuing operations after income taxes | 1,204 | 863 | 941 | 1,216 | 1,822 | |
| Income (loss) from discontinued operations after income taxes | −99 | 56 | −194 | −58 | −53 | |
| Net income (loss) | 1,105 | 919 | 747 | 1,158 | 1,769 | |
| Net income (loss) attributable to noncontrolling interests | 11 | 12 | 12 | 11 | 10 | |
| Net Income (Loss) attributable to Company | 1,094 | 907 | 735 | 1,147 | 1,759 | |
| Basic earnings (loss) per share of common stock from continuing operations | 1.75 | 1.23 | 1.31 | 1.67 | 2.46 | |
| Basic earnings (loss) per share of common stock from discontinued operations | −0.15 | 0.08 | −0.27 | −0.08 | −0.07 | |
| Basic earnings (loss) per share of common stock | 1.6 | 1.31 | 1.04 | 1.59 | 2.39 | |
| Diluted earnings (loss) per share of common stock from continuing operations | 1.75 | 1.22 | 1.3 | 1.66 | 2.44 | |
| Diluted earnings (loss) per share of common stock from discontinued operations | −0.15 | 0.08 | −0.27 | −0.08 | −0.07 | |
| Diluted earnings (loss) per share of common stock | 1.6 | 1.3 | 1.03 | 1.58 | 2.37 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | 4,521 | 3,106 | 2,644 | 3,191 | 4,459 | |
| Marketable Securities | 9 | 63 | 98 | 124 | 86 | |
| Accounts and notes receivable - net | 6,371 | 5,676 | 5,488 | 5,701 | 4,811 | |
| Inventories | 5,667 | 5,432 | 6,899 | 6,811 | 5,180 | |
| Other current assets | 767 | 820 | 1,131 | 968 | 1,010 | |
| Total current assets | 17,335 | 15,097 | 16,260 | 16,795 | 15,546 | |
| Investments in nonconsolidated affiliates | 160 | 134 | 115 | 102 | 76 | |
| Property, Plant and Equipment | 9,551 | 9,074 | 8,956 | 8,551 | 8,364 | |
| Less: Accumulated Depreciation | 5,331 | 4,975 | 4,669 | 4,297 | 4,035 | |
| Net Property, Plant and Equipment | 4,220 | 4,099 | 4,287 | 4,254 | 4,329 | |
| Goodwill | 10,465 | 10,408 | 10,605 | 9,962 | 10,107 | |
| Other intangible assets | 8,301 | 8,876 | 9,626 | 9,339 | 10,044 | |
| Deferred Income Taxes | 320 | 401 | 584 | 479 | 438 | |
| Other Assets | 2,044 | 1,810 | 1,519 | 1,687 | 1,804 | |
| Total Assets | 42,845 | 40,825 | 42,996 | 42,618 | 42,344 | |
| Short-term borrowings and finance lease obligations | 894 | 750 | 198 | 24 | 17 | |
| Accounts Payable | 4,398 | 4,039 | 4,280 | 4,895 | 4,126 | |
| Income Taxes Payable | 155 | 207 | 174 | 183 | 146 | |
| Deferred Revenue | 3,579 | 3,287 | 3,406 | 3,388 | 3,201 | |
| Accrued and other current liabilities | 3,099 | 2,103 | 2,351 | 2,254 | 2,068 | |
| Total current liabilities | 12,125 | 10,386 | 10,409 | 10,744 | 9,558 | |
| Long-term Debt | 1,686 | 1,953 | 2,291 | 1,283 | 1,100 | |
| Deferred Income Tax Liabilities | 251 | 478 | 899 | 1,119 | 1,220 | |
| Pension and other post employment benefits - noncurrent | 2,434 | 2,271 | 2,467 | 2,255 | 3,124 | |
| Other noncurrent obligations | 1,963 | 1,707 | 1,651 | 1,676 | 1,719 | |
| Total Noncurrent Liabilities | 6,334 | 6,409 | 7,308 | 6,333 | 7,163 | |
| Common Stock, Shares, Issued | 672 | 686 | 701 | 713 | — | |
| Common stock | 7 | 7 | 7 | 7 | 7 | |
| Additional Paid in Capital | 27,001 | 27,196 | 27,748 | 27,851 | 27,751 | |
| Retained earnings (accumulated deficit) | −67 | 55 | −41 | 250 | 524 | |
| Accumulated other comprehensive income (loss) | −2,797 | −3,469 | −2,677 | −2,806 | −2,898 | |
| Total stockholders' equity attributable to the company | 24,144 | 23,789 | 25,037 | 25,302 | 25,384 | |
| Noncontrolling Interests | 242 | 241 | 242 | 239 | 239 | |
| Total Equity | 24,386 | 24,030 | 25,279 | 25,541 | 25,623 | |
| Total Liabilities and Equity | 42,845 | 40,825 | 42,996 | 42,618 | 42,344 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 1,203 | 1,227 | 1,211 | 1,223 | 1,243 | |
| Provision for (benefit from) deferred income tax | −41 | −365 | −438 | −288 | — | |
| Net periodic pension and OPEB (benefit) cost, net | 36 | 160 | 138 | −142 | −1,292 | |
| Pension and OPEB contributions | −136 | −151 | −149 | −182 | 247 | |
| Net (gain) loss on sales of property, businesses, consolidated companies and investments | −41 | −17 | −22 | −18 | — | |
| Restructuring and Asset Related Charges - net | 146 | 288 | 336 | 363 | — | |
| Other net loss | 545 | 383 | 578 | 305 | 154 | |
| Accounts and Notes Receivable | −261 | −705 | 358 | −993 | −113 | |
| Inventories | −35 | 1,110 | 57 | −1,715 | −422 | |
| Accounts Payable | 231 | −115 | −663 | 807 | 526 | |
| Deferred Revenue | 270 | −86 | −11 | 194 | 574 | |
| Other Assets and Liabilities | 336 | −296 | −527 | 142 | 57 | |
| Cash Provided by (Used for) Operating Activities - Continuing Operations | 3,457 | 2,296 | 1,809 | 912 | 2,769 | |
| Cash Provided by (Used for) Operating Activities - Discontinued Operations | −51 | −151 | −40 | −40 | −42 | |
| Cash provided by (used for) operating activities | 3,406 | 2,145 | 1,769 | 872 | 2,727 | |
| Capital expenditures | −591 | −597 | −595 | −605 | −573 | |
| Proceeds from Sales of property, businesses, and consolidated companies - net of cash divested | 54 | 5 | 57 | 73 | — | |
| Acquisitions of businesses - Net of Cash Acquired | 0 | 0 | −1,456 | 0 | 0 | |
| Investments in and loans to nonconsolidated affiliates | −20 | −7 | −32 | −12 | −4 | |
| Purchases of investments | 0 | −144 | −148 | −344 | −204 | |
| Proceeds from Sale and Maturities of Investments | 135 | 130 | 147 | 295 | 345 | |
| Payments for (Proceeds from) Hedge, Investing Activities | −83 | 63 | 42 | — | — | |
| Other investing activities - net | −38 | −39 | −2 | −3 | −1 | |
| Cash provided by (used for) investing activities | −543 | −589 | −1,987 | −632 | −362 | |
| Net Change in borrowings (less than 90 days) | 0 | 53 | −6 | −13 | 13 | |
| Proceeds from Debt | 1,730 | 3,072 | 3,429 | 1,358 | 419 | |
| Payments on Debt | −1,871 | −2,885 | −2,309 | −1,140 | −421 | |
| Repurchase of Common Stock | −1,071 | −1,009 | −756 | −1,000 | −950 | |
| Proceeds from Exercise of Stock Options | 88 | 60 | 31 | 88 | 100 | |
| Dividends Paid to stockholders | −475 | −458 | −439 | −418 | −397 | |
| Other financing activities, net | −45 | −32 | −49 | −55 | −30 | |
| Cash provided by (used for) financing activities | −1,644 | −1,199 | −99 | −1,180 | −1,266 | |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents | 84 | −93 | −143 | −278 | −136 | |
| Increase (decrease) on cash, cash equivalents and restricted cash | 1,303 | 264 | −460 | −1,218 | 963 | |
| Interest, net of amounts capitalized | 191 | 244 | 234 | 75 | 30 | |
| Income Taxes | 750 | 707 | 535 | 467 | 341 |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is Corteva, Inc.'s CIK number?
Corteva, Inc.'s SEC CIK number is 0001755672 (1755672). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Corteva, Inc.'s SEC filings?
All of Corteva, Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did Corteva, Inc. last report earnings?
Corteva, Inc. (CTVA) most recently filed an earnings 8-K with the SEC on May 5, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001755672-26-000008). This is Corteva, Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.
What is Corteva, Inc.'s most recent earnings 8-K?
Corteva, Inc.'s latest earnings 8-K (Item 2.02) was filed May 5, 2026 under accession 0001755672-26-000008. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View Corteva, Inc.'s latest earnings 8-K →
Look up any company's CIK number →